Identifying Genes Linked to Dupuytren's Contracture
Author Information
Author(s): Satish Latha, LaFramboise William A, O'Gorman David B, Johnson Sandra, Janto Benjamin, Gan Bing Siang, Baratz Mark E, Hu Fen Z, Post J Christopher, Ehrlich Garth D, Kathju Sandeep
Primary Institution: Center for Genomic Sciences, Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, PA, USA
Hypothesis
The study aims to identify key genes whose regulation might be significantly altered in fibroblasts from Dupuytren's contracture patients compared to controls.
Conclusion
The study identified several candidate genes that may play a role in the pathophysiology of Dupuytren's contracture and could serve as targets for alternative therapies.
Supporting Evidence
- 69 genes were identified as differentially expressed using the CodeLink™ platform.
- 40 genes were identified as downregulated using the Illumina™ platform.
- Quantitative RT-PCR confirmed the downregulation of three candidate genes.
Takeaway
Researchers looked at cells from patients with Dupuytren's contracture to find out which genes are not working properly, hoping to find new ways to treat the disease.
Methodology
Fibroblasts were isolated from Dupuytren's contracture and control patients, and gene expression was analyzed using two microarray platforms.
Limitations
The study may not capture all relevant genes due to the stringent parameters of the analysis.
Participant Demographics
Participants included patients with Dupuytren's contracture and controls undergoing carpal tunnel release, with a higher incidence in men and individuals of Northern European descent.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website